Epidemiology of Human Papillomavirus-Related Head and Neck Cancer

Otolaryngologic Clinics of North America

Volumn 45, Issue 4, 2012, Pages 739-764

  Joseph, Andrew W ^a   D'Souza, Gypsyamber ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; Head and neck cancer; HPV; Human papillomavirus; Oropharyngeal cancer; Squamous cell carcinoma

Indexed keywords

VIRUS DNA;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CIGARETTE SMOKING; DISEASE COURSE; GEOGRAPHIC DISTRIBUTION; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYPOPHARYNX CANCER; LARYNX CANCER; LIP CANCER; MOUTH CANCER; NASOPHARYNX CANCER; NONHUMAN; ORAL SEXUAL CONTACT; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TONSIL CARCINOMA; VIRUS DETECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84863859721     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2012.04.003     Document Type: Review

References (239)

1. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4):612-619.
2. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29(32):4294-4301.
3. Hammarstedt L., Dahlstrand H., Lindquist D., et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007, 127(9):988-992.
4. Hammarstedt L., Lindquist D., Dahlstrand H., et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006, 119(11):2620-2623.
5. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. 2010. Available at: Accessed August 14, 2011. http://globocan.iarc.fr.
6. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4(10):757-768.
7. Schlumberger M.J. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338(5):297-306.
8. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
9. Nair U., Bartsch H., Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004, 19(4):251-262.
10. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
11. Fast Stats: An interactive tool for access to SEER cancer statistics. Available at: Accessed August 8, 2011. http://seer.cancer.gov/faststats.
12. Howlader N, Noone AM, Krapcho M, et al, editor. SEER Cancer Statistics Review, 1975-2008. Bethesda (MD): National Cancer Institute. Available at: based on November 2010 SEER data submission, posted to the SEER web site, 2011. Accessed April 19, 2012. http://seer.cancer.gov/csr/1975_2009_pops09/.
13. Hashibe M., Brennan P., Chuang S.C., et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009, 18(2):541-550.
14. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004, 83:1-1438.
15. Sturgis E.M., Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 2007, 110(7):1429-1435.
16. NCI Monograph No. 8. Changes in cigarette-related disease risks and their implication for prevention and control. Report of the NCI Expert Committee. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1997.
17. Carvalho A.L., Nishimoto I.N., Califano J.A., et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005, 114(5):806-816.
18. Karim-Kos H.E., de Vries E., Soerjomataram I., et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44(10):1345-1389.
19. Davis S., Severson R.K. Increasing incidence of cancer of the tongue in the United States among young adults. Lancet 1987, 2(8564):910-911.
20. Macfarlane G.J., Boyle P., Scully C. Oral cancer in Scotland: changing incidence and mortality. BMJ 1992, 305(6862):1121-1123.
21. Shemen L.J., Klotz J., Schottenfeld D., et al. Increase of tongue cancer in young men. JAMA 1984, 252(14):1857.
22. Depue R.H. Rising mortality from cancer of the tongue in young white males. N Engl J Med 1986, 315(10):647.
23. Annertz K., Anderson H., Biorklund A., et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002, 101(1):95-99.
24. Kari S., Alho O.P., Jokinen K., et al. Carcinoma of the oral tongue in northern Finland: trends in overall incidence and patient and tumour characteristics. J Oral Pathol Med 1997, 26(10):480-483.
25. Shiboski C.H., Schmidt B.L., Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005, 103(9):1843-1849.
26. Patel S.C., Carpenter W.R., Tyree S., et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011, 29(11):1488-1494.
27. Franceschi S., Bidoli E., Herrero R., et al. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000, 36(1):106-115.
28. Hindle I., Downer M.C., Speight P.M. The epidemiology of oral cancer. Br J Oral Maxillofac Surg 1996, 34(5):471-476.
29. Johnson N.W., Warnakulasuriya K.A. Epidemiology and aetiology of oral cancer in the United Kingdom. Community Dent Health 1993, 10(Suppl 1):13-29.
30. Macfarlane G.J., Boyle P., Evstifeeva T.V., et al. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 1994, 5(3):259-265.
31. Mork J., Glattre E. Squamous cell carcinomas of the head and neck in Norway, 1953-92: an epidemiologic study of a low-risk population. Cancer Causes Control 1998, 9(1):37-48.
32. Frisch M., Hjalgrim H., Jaeger A.B., et al. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000, 11(6):489-495.
33. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004, 57(5):449-455.
34. Auluck A., Hislop G., Bajdik C., et al. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010, 116(11):2635-2644.
35. Plesko I., Macfarlane G.J., Evstifeeva T.V., et al. Oral and pharyngeal cancer incidence in Slovakia 1968-1989. Int J Control 1994, 56(4):481-486.
36. Conway D.I., Stockton D.L., Warnakulasuriya K.A., et al. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999)-recent trends and regional variation. Oral Oncol 2006, 42(6):586-592.
37. Robinson K.L., Macfarlane G.J. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing?. Oral Oncol 2003, 39(1):31-36.
38. Blomberg M., Nielsen A., Munk C., et al. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2011, 129(3):733-741.
39. Nelson D.E., Mowery P., Tomar S., et al. Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Public Health 2006, 96(5):897-905.
40. Kojima A., Maeda H., Kurahashi N., et al. Human papillomaviruses in the normal oral cavity of children in Japan. Oral Oncol 2003, 39(8):821-828.
41. Marur S., D'Souza G., Westra W.H., et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11(8):781-789.
42. Syrjanen S. Human papillomaviruses in head and neck carcinomas. N Engl J Med 2007, 356(19):1993-1995.
43. Kreimer A.R., Clifford G.M., Boyle P., et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14(2):467-475.
44. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720.
45. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356(19):1944-1956.
46. Hobbs C.G., Sterne J.A., Bailey M., et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006, 31(4):259-266.
47. Smith E.M., Ritchie J.M., Summersgill K.F., et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004, 108(5):766-772.
48. Koch W.M., Lango M., Sewell D., et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109(10):1544-1551.
49. Ritchie J.M., Smith E.M., Summersgill K.F., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003, 104(3):336-344.
50. Schwartz S.M., Daling J.R., Doody D.R., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998, 90(21):1626-1636.
51. Strome S.E., Savva A., Brissett A.E., et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 2002, 8(4):1093-1100.
52. Cruz I.B., Snijders P.J., Steenbergen R.D., et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 1996, 32B(1):55-62.
53. Fouret P., Monceaux G., Temam S., et al. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997, 123(5):513-516.
54. Klussmann J.P., Weissenborn S.J., Wieland U., et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001, 92(11):2875-2884.
55. Lindel K., Beer K.T., Laissue J., et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001, 92(4):805-813.
56. Nasman A., Attner P., Hammarstedt L., et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009, 125(2):362-366.
57. Romanitan M., Nasman A., Ramqvist T., et al. Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res 2008, 28(4B):2077-2080.
58. Tachezy R., Klozar J., Rubenstein L., et al. Demographic and risk factors in patients with head and neck tumors. J Med Virol 2009, 81(5):878-887.
59. Tachezy R., Klozar J., Salakova M., et al. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis 2005, 11(3):181-185.
60. van Houten V.M., Snijders P.J., van den Brekel M.W., et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001, 93(2):232-235.
61. Ernster J.A., Sciotto C.G., O'Brien M.M., et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007, 117(12):2115-2128.
62. Lundberg M., Leivo I., Saarilahti K., et al. Increased incidence of oropharyngeal cancer and p16 expression. Acta Otolaryngol 2011, 131(9):1008-1011.
63. Hansson B.G., Rosenquist K., Antonsson A., et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005, 125(12):1337-1344.
64. Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95(23):1772-1783.
65. Maden C., Beckmann A.M., Thomas D.B., et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992, 135(10):1093-1102.
66. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344(15):1125-1131.
67. Van Doornum G.J., Korse C.M., Buning-Kager J.C., et al. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer 2003, 88(7):1095-1100.
68. Dahlstrom K.R., Adler-Storthz K., Etzel C.J., et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 2003, 9(7):2620-2626.
69. Smith E.M., Ritchie J.M., Summersgill K.F., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004, 96(6):449-455.
70. Smith E.M., Ritchie J.M., Pawlita M., et al. Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 2007, 120(4):825-832.
71. Agrawal Y., Koch W.M., Xiao W., et al. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res 2008, 14(21):7143-7150.
72. Baumann J.L., Cohen S., Evjen A.N., et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope 2009, 119(8):1531-1537.
73. Capone R.B., Pai S.I., Koch W.M., et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000, 6(11):4171-4175.
74. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-269.
75. Furniss C.S., McClean M.D., Smith J.F., et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007, 120(11):2386-2392.
76. Gillison M.L., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100(6):407-420.
77. Haraf D.J., Nodzenski E., Brachman D., et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996, 2(4):755-762.
78. Olshan A.F., Weissler M.C., Pei H., et al. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997, 14(7):811-818.
79. Paz I.B., Cook N., Odom-Maryon T., et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79(3):595-604.
80. Settle K., Posner M.R., Schumaker L.M., et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) 2009, 2(9):776-781.
81. Shen J., Tate J.E., Crum C.P., et al. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol 1996, 9(1):15-20.
82. Westra W.H., Taube J.M., Poeta M.L., et al. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008, 14(2):366-369.
83. Zhao M., Rosenbaum E., Carvalho A.L., et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005, 117(4):605-610.
84. Almadori G., Cadoni G., Cattani P., et al. Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 1996, 32A(5):783-788.
85. Alvarez Alvarez I., Sanchez Lazo P., Ramos Gonzalez S., et al. Using polymerase chain reaction to human papillomavirus in oral and pharyngolaryngeal carcinomas. Am J Otolaryngol 1997, 18(6):375-381.
86. Anderson C.E., McLaren K.M., Rae F., et al. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland. J Clin Pathol 2007, 60(4):439-441.
87. Anwar K., Nakakuki K., Naiki H., et al. ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer 1993, 53(1):22-28.
88. Atula S., Auvinen E., Grenman R., et al. Human papillomavirus and Epstein-Barr virus in epithelial carcinomas of the head and neck region. Anticancer Res 1997, 17(6D):4427-4433.
89. Azzimonti B., Pagano M., Mondini M., et al. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology 2004, 45(6):560-572.
90. Badaracco G., Rizzo C., Mafera B., et al. Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep 2007, 17(4):931-939.
91. Baez A., Almodovar J.I., Cantor A., et al. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 2004, 26(9):778-784.
92. Bhattacharya N., Roy A., Roy B., et al. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients. J Oral Pathol Med 2009, 38(10):759-763.
93. Boscolo-Rizzo P., Da Mosto M.C., Fuson R., et al. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol 2009, 135(4):559-566.
94. Cattani P., Hohaus S., Bellacosa A., et al. Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 1998, 4(11):2585-2589.
95. Cerovac Z., Sarcevic B., Kralj Z., et al. Detection of human papillomavirus (HPV) type 6, 16 and 18 in head and neck squamous cell carcinomas by in situ hybridization. Neoplasma 1996, 43(3):185-194.
96. de Oliveira D.E., Bacchi M.M., Macarenco R.S., et al. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol 2006, 126(2):284-293.
97. Deng Z., Hasegawa M., Matayoshi S., et al. Prevalence and clinical features of human papillomavirus in head and neck squamous cell carcinoma in Okinawa, southern Japan. Eur Arch Otorhinolaryngol 2011, 268(11):1625-1631.
98. Fischer M. Analysis of exon 2 of MTS1 in HPV-positive and HPV-negative tumors of the head and neck region. Eur Arch Otorhinolaryngol 2007, 264(7):801-807.
99. Fischer M., von Winterfeld F. Evaluation and application of a broad-spectrum polymerase chain reaction assay for human papillomaviruses in the screening of squamous cell tumours of the head and neck. Acta Otolaryngol 2003, 123(6):752-758.
100. Fouret P., Martin F., Flahault A., et al. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995, 4(2):122-127.
101. Gallo A., Degener A.M., Pagliuca G., et al. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg 2009, 141(2):276-281.
102. Garcia-Milian R., Hernandez H., Panade L., et al. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 1998, 118(5):754-758.
103. Gorgoulis V., Rassidakis G., Karameris A., et al. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch 1994, 425(5):481-489.
104. Gorgoulis V.G., Zacharatos P., Kotsinas A., et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999, 30(3):274-283.
105. Gudleviciene Z., Smailyte G., Mickonas A., et al. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer. Oncology 2009, 76(3):205-208.
106. Guvenc M.G., Midilli K., Ozdogan A., et al. Detection of HHV-8 and HPV in laryngeal carcinoma. Auris Nasus Larynx 2008, 35(3):357-362.
107. Hoffmann M., Gorogh T., Gottschlich S., et al. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 2005, 218(2):199-206.
108. Hoffmann M., Kahn T., Mahnke C.G., et al. Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol 1998, 118(1):138-144.
109. Hoffmann M., Orlamunder A., Sucher J., et al. HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers. Anticancer Res 2006, 26(1B):663-670.
110. Hoffmann M., Scheunemann D., Fazel A., et al. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma. Oncol Rep 2009, 21(3):809-814.
111. Kleist B., Poetsch M., Bankau A., et al. First hints for a correlation between amplification of the Int-2 gene and infection with human papillomavirus in head and neck squamous cell carcinomas. J Oral Pathol Med 2000, 29(9):432-437.
112. Koskinen W.J., Brondbo K., Mellin Dahlstrand H., et al. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 2007, 133(9):673-678.
113. Koskinen W.J., Chen R.W., Leivo I., et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003, 107(3):401-406.
114. Lee S.Y., Cho N.H., Choi E.C., et al. Is human papillomavirus a causative factor of glottic cancer?. J Voice 2011, 25(6):770-774.
115. Lie E.S., Karlsen F., Holm R. Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization. Acta Otolaryngol 1996, 116(6):900-905.
116. Lindeberg H., Krogdahl A. Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 1999, 146(1):9-13.
117. Major T., Szarka K., Sziklai I., et al. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 2005, 58(1):51-55.
118. Manjarrez M.E., Ocadiz R., Valle L., et al. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res 2006, 12(23):6946-6951.
119. Miranda F.A., Hassumi M.K., Guimaraes M.C., et al. Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis. J Histochem Cytochem 2009, 57(7):665-673.
120. Mitra S., Banerjee S., Misra C., et al. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol 2007, 60(9):1040-1047.
121. Morshed K. Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol 2010, 82(6):1017-1023.
122. Morshed K., Korobowicz E., Szymanski M., et al. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2005, 262(11):917-920.
123. Morshed K., Polz-Dacewicz M., Szymanski M., et al. Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation. Eur Arch Otorhinolaryngol 2008, 265(Suppl 1):S89-S96.
124. Morshed K., Polz-Dacewicz M., Szymanski M., et al. Usefulness and efficiency of formalin-fixed paraffin-embedded specimens from laryngeal squamous cell carcinoma in HPV detection by IHC and PCR/DEIA. Folia Histochem Cytobiol 2010, 48(3):398-402.
125. Nishioka S., Fukushima K., Nishizaki K., et al. Human papillomavirus as a risk factor for head and neck cancers-a case-control study. Acta Otolaryngol Suppl 1999, 540:77-80.
126. Ogura H., Watanabe S., Fukushima K., et al. Presence of human papillomavirus type 18 DNA in a pharyngeal and a laryngeal carcinoma. Jpn J Cancer Res 1991, 82(11):1184-1186.
127. Peralta R., Baudis M., Vazquez G., et al. Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2010, 136(6):931-938.
128. Poljak M., Gale N., Kambic V. Human papillomaviruses: a study of their prevalence in the epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 1997, 527:66-69.
129. Ritta M., De Andrea M., Mondini M., et al. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009, 31(3):318-327.
130. Sabbir M.G., Dasgupta S., Roy A., et al. Genetic alterations (amplification and rearrangement) of D-type cyclins loci in head and neck squamous cell carcinoma of Indian patients: prognostic significance and clinical implications. Diagn Mol Pathol 2006, 15(1):7-16.
131. Salam M.A., Rockett J., Morris A. General primer-mediated polymerase chain reaction for simultaneous detection and typing of human papillomavirus DNA in laryngeal squamous cell carcinomas. Clin Otolaryngol Allied Sci 1995, 20(1):84-88.
132. Snijders P.J., Scholes A.G., Hart C.A., et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996, 66(4):464-469.
133. Torrente M.C., Ampuero S., Abud M., et al. Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol 2005, 125(8):888-893.
134. Tyan Y.S., Liu S.T., Ong W.R., et al. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors. J Clin Microbiol 1993, 31(1):53-56.
135. Venuti A., Manni V., Morello R., et al. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000, 60(4):396-402.
136. Vlachtsis K., Nikolaou A., Markou K., et al. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005, 262(11):890-898.
137. Brandsma J.L., Abramson A.L. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989, 115(5):621-625.
138. Smith E.M., Summersgill K.F., Allen J., et al. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 2000, 109(11):1069-1076.
139. Dillner J., Knekt P., Schiller J.T., et al. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995, 311(7016):1346.
140. Cook J.R., Hill D.A., Humphrey P.A., et al. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 2000, 13(8):914-918.
141. Lin H.W., Richmon J.D., Emerick K.S., et al. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 2010, 31(4):291-296.
142. Reidy P.M., Dedo H.H., Rabah R., et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004, 114(11):1906-1909.
143. Gerein V., Rastorguev E., Gerein J., et al. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol 2005, 114(6):463-471.
144. Klozar J., Taudy M., Betka J., et al. Laryngeal papilloma-precancerous condition?. Acta Otolaryngol Suppl 1997, 527:100-102.
145. Hartley C., Hamilton J., Birzgalis A.R., et al. Recurrent respiratory papillomatosis-the Manchester experience, 1974-1992. J Laryngol Otol 1994, 108(3):226-229.
146. Donne A.J., Hampson L., Homer J.J., et al. The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol 2010, 74(1):7-14.
147. Torrente M.C., Rodrigo J.P., Haigentz M., et al. Human papillomavirus infections in laryngeal cancer. Head Neck 2011, 33(4):581-586.
148. Lopes V., Murray P., Williams H., et al. Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Oral Oncol 2011, 47(8):698-701.
149. Zhang Z.Y., Sdek P., Cao J., et al. Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int J Oral Maxillofac Surg 2004, 33(1):71-74.
150. Huang L.W., Seow K.M. Oral sex is a risk factor for human papillomavirus-associated nasopharyngeal carcinoma in husbands of women with cervical cancer. Gynecol Obstet Invest 2010, 70(2):73-75.
151. Laantri N., Attaleb M., Kandil M., et al. Human papillomavirus detection in Moroccan patients with nasopharyngeal carcinoma. Infect Agent Cancer 2011, 6(1):3.
152. Lo E.J., Bell D., Woo J.S., et al. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope 2010, 120(10):1990-1997.
153. Maxwell J.H., Kumar B., Feng F.Y., et al. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck 2010, 32(5):562-567.
154. Mineta H., Ogino T., Amano H.M., et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 1998, 18(6B):4765-4768.
155. Mirzamani N., Salehian P., Farhadi M., et al. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. Exp Mol Pathol 2006, 81(3):231-234.
156. Singhi A.D., Califano J., Westra W.H. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2012, 34(2):213-218.
157. Bryan R.L., Bevan I.S., Crocker J., et al. Detection of HPV 6 and 11 in tumours of the upper respiratory tract using the polymerase chain reaction. Clin Otolaryngol Allied Sci 1990, 15(2):177-180.
158. Kassim S.K., Ibrahim S.A., Eissa S., et al. Epstein-Barr virus, human papillomavirus, and flow cytometric cell cycle kinetics in nasopharyngeal carcinoma and inverted papilloma among Egyptian patients. Dis Markers 1998, 14(2):113-120.
159. Krishna S.M., James S., Kattoor J., et al. Human papilloma virus infection in Indian nasopharyngeal carcinomas in relation to the histology of tumour. Indian J Pathol Microbiol 2004, 47(2):181-185.
160. Huang C.C., Hsiao J.R., Yang M.W., et al. Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol 2011, 64(7):571-577.
161. Licitra L., Zigon G., Gatta G., et al. Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am 2008, 22(6):1143. viii.
162. Hocking J.S., Stein A., Conway E.L., et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011, 104(5):886-891.
163. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527.
164. Schiffman M., Clifford G., Buonaguro F.M. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009, 4:8.
165. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19.
166. Gillison M.L., Lowy D.R. A causal role for human papillomavirus in head and neck cancer. Lancet 2004, 363(9420):1488-1489.
167. Kreimer A.R., Alberg A.J., Daniel R., et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004, 189(4):686-698.
168. Kreimer A.R., Villa A., Nyitray A.G., et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011, 20(1):172-182.
169. Matsushita K., Sasagawa T., Miyashita M., et al. Oral and cervical human papillomavirus infection among female sex workers in Japan. Jpn J Infect Dis 2011, 64(1):34-39.
170. Parisi S.G., Cruciani M., Scaggiante R., et al. Anal and oral human papillomavirus (HPV) infection in HIV infected subjects in Northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis 2011, 11(1):150.
171. Boonyanurak P., Panichakul S., Wilawan K. Prevalence of high-risk human papillomavirus infection (HPV) and correlation with postmenopausal hormonal therapy in Thai women aged more than 45 years old. J Med Assoc Thai 2010, 93(1):9-16.
172. Esquenazi D., Bussoloti F.I., Carvalho M.G., et al. The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz J Otorhinolaryngol 2010, 76(1):78-84.
173. Termine N., Giovannelli L., Matranga D., et al. Low rate of oral human papillomavirus (HPV) infection in women screened for cervical HPV infection in Southern Italy: a cross-sectional study of 140 immunocompetent subjects. J Med Virol 2009, 81(8):1438-1443.
174. do Sacramento P.R., Babeto E., Colombo J., et al. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population. J Med Virol 2006, 78(5):614-618.
175. D'Souza G., Agrawal Y., Halpern J., et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009, 199(9):1263-1269.
176. Smith E.M., Ritchie J.M., Yankowitz J., et al. HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infect Dis Obstet Gynecol 2004, 12(2):45-56.
177. Smith E.M., Swarnavel S., Ritchie J.M., et al. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 2007, 26(9):836-840.
178. Summersgill K.F., Smith E.M., Levy B.T., et al. Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91(1):62-69.
179. Kreimer A.R., Bhatia R.K., Messeguer A.L., et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010, 37(6):386-391.
180. D'Souza G., Fakhry C., Sugar E.A., et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007, 121(1):143-150.
181. Huh W.K. Human papillomavirus infection: a concise review of natural history. Obstet Gynecol 2009, 114(1):139-143.
182. Insinga R.P., Dasbach E.J., Elbasha E.H. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009, 9:119.
183. Kurose K., Terai M., Soedarsono N., et al. Low prevalence of HPV infection and its natural history in normal oral mucosa among volunteers on Miyako Island, Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98(1):91-96.
184. Rintala M., Grenman S., Puranen M., et al. Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study. J Clin Virol 2006, 35(1):89-94.
185. Rintala M.A., Grenman S.E., Jarvenkyla M.E., et al. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 2005, 41(12):1728-1733.
186. D'Souza G, Kluz N, Stammer E, et al. Oral HPV prevalence and persistence among high risk young adults. 27th International Papillomavirus Conference and Clinical Workshop. Berlin, September 17-22, 2011. Poster P-16.36.
187. Benard V.B., Johnson C.J., Thompson T.D., et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008, 113(Suppl 10):2910-2918.
188. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363(1):24-35.
189. Beachler D.C., D'Souza G. Nuances in the changing epidemiology of head and neck cancer. Oncology 2010, 24(10):924-926.
190. Ryerson A.B., Peters E.S., Coughlin S.S., et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008, 113(Suppl 10):2901-2909.
191. Rajkumar T., Sridhar H., Balaram P., et al. Oral cancer in Southern India: the influence of body size, diet, infections and sexual practices. Eur J Cancer Prev 2003, 12(2):135-143.
192. Rosenquist K., Wennerberg J., Schildt E.B., et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005, 125(12):1327-1336.
193. Heck J.E., Berthiller J., Vaccarella S., et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010, 39(1):166-181.
194. D'Souza G., Zhang H.H., D'Souza W.D., et al. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol 2010, 46(2):100-104.
195. Maxwell J.H., Kumar B., Feng F.Y., et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010, 16(4):1226-1235.
196. Schrank T.P., Han Y., Weiss H., et al. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States-possible role for human papillomavirus in survival disparities. Head Neck 2011, 33(1):45-53.
197. Ringstrom E., Peters E., Hasegawa M., et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002, 8(10):3187-3192.
198. Fukushima K., Ogura H., Watanabe S., et al. Human papillomavirus type 16 DNA detected by the polymerase chain reaction in non-cancer tissues of the head and neck. Eur Arch Otorhinolaryngol 1994, 251(2):109-112.
199. Anaya-Saavedra G., Ramirez-Amador V., Irigoyen-Camacho M.E., et al. High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008, 39(2):189-197.
200. Balaram P., Nalinakumari K.R., Abraham E., et al. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 1995, 61(4):450-454.
201. Campisi G., Giovannelli L., Calvino F., et al. HPV infection in relation to OSCC histological grading and TNM stage. Evaluation by traditional statistics and fuzzy logic model. Oral Oncol 2006, 42(6):638-645.
202. Cunningham L.L., Pagano G.M., Li M., et al. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102(1):77-81.
203. da Silva C.E., da Silva I.D., Cerri A., et al. Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104(4):497-500.
204. D'Costa J., Saranath D., Dedhia P., et al. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998, 34(5):413-420.
205. Hafkamp H.C., Speel E.J., Haesevoets A., et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003, 107(3):394-400.
206. Ibieta B.R., Lizano M., Fras-Mendivil M., et al. Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 99(3):311-315.
207. Ishibashi M., Kishino M., Sato S., et al. The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control. Int J Clin Oncol 2011, 16(6):646-653.
208. Jalouli J., Ibrahim S.O., Sapkota D., et al. Presence of human papilloma virus, herpes simplex virus and Epstein-Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use. J Oral Pathol Med 2010, 39(8):599-604.
209. Joo Y.H., Jung C.K., Sun D.I., et al. High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer. Head Neck 2012, 34(1):10-14.
210. Koppikar P., deVilliers E.M., Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005, 113(6):946-950.
211. Kozomara R., Jovic N., Magic Z., et al. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg 2005, 33(5):342-348.
212. Lee S.Y., Cho N.H., Choi E.C., et al. Relevance of human papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral Maxillofac Surg 2010, 39(7):678-683.
213. Liang X.H., Lewis J., Foote R., et al. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 2008, 66(9):1875-1880.
214. Lohavanichbutr P., Houck J., Fan W., et al. Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch Otolaryngol Head Neck Surg 2009, 135(2):180-188.
215. Machado J., Reis P.P., Zhang T., et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2010, 2:6.
216. Mao E.J., Schwartz S.M., Daling J.R., et al. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 1996, 69(2):152-158.
217. Mendelsohn A.H., Lai C.K., Shintaku I.P., et al. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010, 120(9):1788-1794.
218. Nagpal J.K., Patnaik S., Das B.R. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 2002, 97(5):649-653.
219. Nemes J.A., Deli L., Nemes Z., et al. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102(3):344-352.
220. Oliveira L.R., Ribeiro-Silva A., Ramalho L.N., et al. HPV infection in Brazilian oral squamous cell carcinoma patients and its correlation with clinicopathological outcomes. Mol Med Report 2008, 1(1):123-129.
221. Oliveira M.C., Soares R.C., Pinto L.P., et al. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas. Auris Nasus Larynx 2009, 36(4):450-456.
222. Premoli-De-Percoco G., Ramirez J.L. High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in a Venezuelan rural population. Preliminary report. J Oral Pathol Med 2001, 30(6):355-361.
223. Ragin C.C., Taioli E., Weissfeld J.L., et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006, 95(10):1432-1438.
224. Ribeiro K.B., Levi J.E., Pawlita M., et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 2011, 40(2):489-502.
225. Riethdorf S., Friedrich R.E., Ostwald C., et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997, 26(7):315-321.
226. Rivero E.R., Nunes F.D. HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR. Braz Oral Res 2006, 20(1):21-24.
227. Saini R., Tang T.H., Zain R.B., et al. Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol 2011, 137(2):311-320.
228. Scapoli L., Palmieri A., Rubini C., et al. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol 2009, 22(3):366-372.
229. Simonato L.E., Garcia J.F., Sundefeld M.L., et al. Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival. J Oral Pathol Med 2008, 37(10):593-598.
230. Smith E.M., Rubenstein L.M., Hoffman H., et al. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010, 5:4.
231. Soares R.C., Oliveira M.C., Souza L.B., et al. Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients. Am J Otolaryngol 2007, 28(6):397-400.
232. St Guily J.L., Jacquard A.C., Pretet J.L., et al. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France-the EDiTH VI study. J Clin Virol 2011, 51(2):100-104.
233. Sugiyama M., Bhawal U.K., Dohmen T., et al. Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95(5):594-600.
234. Tang X., Jia L., Ouyang J., et al. Comparative study of HPV prevalence in Japanese and North-east Chinese oral carcinoma. J Oral Pathol Med 2003, 32(7):393-398.
235. Tsuhako K., Nakazato I., Miyagi J., et al. Comparative study of oral squamous cell carcinoma in Okinawa, Southern Japan and Sapporo in Hokkaido, Northern Japan; with special reference to human papillomavirus and Epstein-Barr virus infection. J Oral Pathol Med 2000, 29(2):70-79.
236. Weiss D., Koopmann M., Rudack C. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 2011, 33(6):856-862.
237. Yamakawa-Kakuta Y., Kawamata H., Doi Y., et al. Does the expression of HPV16/18 E6/E7 in head and neck squamous cell carcinomas relate to their clinicopathological characteristics?. Int J Oncol 2009, 35(5):983-988.
238. Gungor A., Cincik H., Baloglu H., et al. Human papilloma virus prevalence in laryngeal squamous cell carcinoma. J Laryngol Otol 2007, 121(8):772-774.
239. Rodrigo J.P., Gonzalez M.V., Lazo P.S., et al. Genetic alterations in squamous cell carcinomas of the hypopharynx with correlations to clinicopathological features. Oral Oncol 2002, 38(4):357-363.